BillsSS. 1041
Affordable Prescriptions for Patients Act
Stage
In other chamber
Latest action
Held at the desk.
July 21, 2026
Summary
Affordable Prescriptions for Patients Act This bill limits in certain instances the number of patents that the manufacturer of a biologic drug can assert in a lawsuit against a company seeking to sell
Committees
- PrimaryJudiciary Committee
CRS subjects
Civil actions and liabilityCompetition and antitrustConsumer affairs
Action history
- March 13, 2025Introduced in Senate
- March 13, 2025Read twice and referred to the Committee on the Judiciary.
- April 3, 2025Committee on the Judiciary. Ordered to be reported with amendments favorably.
- April 10, 2025Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- April 10, 2025Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- April 10, 2025Placed on Senate Legislative Calendar under General Orders. Calendar No. 44.
- July 21, 2026Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.
- July 21, 2026Passed Senate with amendments by Unanimous Consent. (consideration: CR S4198-4199; text: CR S4199)
- July 21, 2026Message on Senate action sent to the House.
- July 21, 2026Received in the House.
- July 21, 2026Held at the desk.
Cosponsors (3)
Text versions
- Introduced in SenateMarch 13, 2025
- Reported to SenateApril 10, 2025
- Engrossed in SenateJuly 21, 2026